PRE 14A

PRELIMINARY PROXY STATEMENT

Company: ELITE PHARMACEUTICALS INC /NV/
Filed: April 17, 2020
Period of Report: April 17, 2020
Accession Number: 0001213900-20-009462

View Document ↗ View on SEC.gov ↗